FORMULATION AND DEVELOPMENT OF MUCOADHESIVE TABLETS OF LAMIVUDINE USING DIRECT COMPRESSION TECHNIQUE
The objective of the present work is to design mucoadhesive tablets of lamivudine for oral controlled release by direct compression using different binders. Lamivudine is anti viral drug used in the treatment of hepatitis B and HIV infections. It has a shorter half-life of 2-6 hrs, oral availability is 86% and it is eliminated rapidly from the plasma compartment within few hours. So, frequent administration is necessary to maintain its therapeutic concentration. In order to maintain the therapeutic concentrations of lamivudine modified release formulations are necessary. In the present work the mucoadhesive tablets of lamivudine was prepared to prolong the residence time at the site of application (or) absorption and to facilitate the intimate contact with the underlying absorption surface to improve and enhance the bioavailability. The mucoadhesive tablets of lamivudine were prepared by using Carbopol, Hydroxy propyl methylcellulose, xanthan gum.
Authors
- E. Gopinath
- S. Monesh
- K. Lousion
- Sathyaraj. A.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24300843
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00